ROCKET PHARMACEUTICALS, INC. (RCKTW) Return on equity 2016–2025
ROCKET PHARMACEUTICALS, INC. (RCKTW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-80.5%FY2025 · since FY2016: -90.5% → -80.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -80.5% | -24.6 pp |
| FY2024 | -55.9% | -6.0 pp |
| FY2023 | -49.9% | -4.6 pp |
| FY2022 | -45.3% | -8.1 pp |
| FY2021 | -37.2% | -9.4 pp |
| FY2020 | -27.7% | -2.6 pp |
| FY2019 | -25.1% | +13.3 pp |
| FY2018 | -38.4% | +87.8 pp |
| FY2017 | -126.2% | -35.7 pp |
| FY2016 | -90.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice